Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Liabilities (2016 - 2025)

Sanofi (SNY) has disclosed Total Liabilities for 11 consecutive years, with $64.5 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 9.2% to $64.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.5 billion through Dec 2025, up 9.2% year-over-year, with the annual reading at $62.6 billion for FY2025, 4.65% up from the prior year.
  • Total Liabilities hit $64.5 billion in Q4 2025 for Sanofi, up from $59.1 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $64.5 billion in Q4 2025 to a low of -$78.6 billion in Q4 2021.
  • Historically, Total Liabilities has averaged $30.9 billion across 5 years, with a median of $56.4 billion in 2023.
  • Biggest five-year swings in Total Liabilities: decreased 4.42% in 2021 and later skyrocketed 167.44% in 2022.
  • Year by year, Total Liabilities stood at -$78.6 billion in 2021, then surged by 167.44% to $53.0 billion in 2022, then grew by 6.45% to $56.4 billion in 2023, then grew by 4.75% to $59.1 billion in 2024, then rose by 9.2% to $64.5 billion in 2025.
  • Business Quant data shows Total Liabilities for SNY at $64.5 billion in Q4 2025, $59.1 billion in Q4 2024, and $56.4 billion in Q4 2023.